Breaking news

SMA-PAR, a study of the parenthood experience of parents of children with SMA conducted by Sophie Boursange

02 April 2021

DMD: start at I-Motion of a gene therapy trial using a microdystrophin designed by Genethon in collaboration with Sarepta Therapeutics

01 March 2021

Dr Emmanuelle Lagrue, MD-PhD, pediatric neurologist, joins Généthon and I-Motion

23 October 2020

COVID-19, consultations and clinical trials: 6 questions for Dominique Duchêne


17 June 2020

Odile Boespflug-Tanguy, the Head of I-Motion: strengthening the links between preclinical research, clinical research and care

03 November 2019